Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
There is no recognized protein named "Four and a half LIM domains 5" in current biological or biomedical databases, nor in the referenced scientific literature. The family of "Four and a half LIM domain proteins" consists of four main members: FHL1, FHL2, FHL3, and FHL4. These are zinc finger proteins with important roles in striated muscle, cardiac hypertrophy, and other processes, but there is no evidence for a fifth ("5") member named as such[2]. The four-member FHL family (FHL1–FHL4) is well-studied, with roles as protein–protein interaction platforms, particularly in muscle tissue and cardiac physiology, but the existence of "FHL5" is not supported in scientific publications or genetic/protein databases[2]. If you meant a member of the FHL family (such as FHL1, FHL2, FHL3, or FHL4), please specify for more detailed information. If "Four and a half LIM domains 5" was a search or data entry mistake, the target does not exist as named (hence, is_incorrect: true). If you meant another protein (e.g., FHL1–FHL4, or LIM domain-containing protein 5), clarification is needed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Four and a half LIM domains protein 5 (FHL5).